THX Pharma (FRA:3VG) Pretax Margin %: % (As of Dec. 2025)

What is THX Pharma Pretax Margin %?

THX Pharma FRA:3VG +1.10% 30 Pretax Margin % is % as of Dec. 2025. GuruFocus rates FRA:3VG with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 947 Biotechnology companies, THX Pharma ranks worse than 105596.52% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. THX Pharma's Pre-Tax Income for the six months ended in Dec. 2025 was €-2.85 Mil. THX Pharma's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, THX Pharma's pretax margin for the quarter that ended in Dec. 2025 was %.

The historical rank and industry rank for THX Pharma's Pretax Margin % or its related term are showing as below:

FRA:3VG's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -90.63
* Ranked among companies with meaningful Pretax Margin % only.

THX Pharma (FRA:3VG) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

THX Pharma Pretax Margin % Related Terms

THX Pharma Pretax Margin % Historical Data

* Premium members only.

The historical data trend for THX Pharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THX Pharma Pretax Margin % Chart

THX Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Pretax Margin %

Get a 7-Day Free Trial

0.00

THX Pharma Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Pretax Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

FRA:3VG vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, THX Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

THX Pharma Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, THX Pharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where THX Pharma's Pretax Margin % falls into.

Save Embed

30GF Score

THX Pharma FRA:3VG

Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

THX Pharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

THX Pharma's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-4	/	0
	=	%

THX Pharma's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-2.847	/	0
	=	%

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of % mean?

THX Pharma (FRA:3VG) has a Pretax Margin % of % as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on THX Pharma and its competitors. According to the industry distribution chart, THX Pharma ranks #999999 out of 947 companies in the Biotechnology industry.

Is THX Pharma's Pretax Margin % too high?

THX Pharma's current Pretax Margin % is %. Based on the distribution chart, THX Pharma ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, THX Pharma has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.

How does THX Pharma's Pretax Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, THX Pharma ranks #999999 out of 947 companies for Pretax Margin %. This places THX Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on THX Pharma and its competitors. THX Pharma's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is THX Pharma stock overvalued right now?

THX Pharma (FRA:3VG) has a current Pretax Margin % of %. The current Pretax Margin % is %. THX Pharma's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For THX Pharma (FRA:3VG), the current Pretax Margin % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THX Pharma Business Description

Industry Healthcare Biotechnology

Comparable Companies XPAR:MAAT XPAR:ALGAE XPAR:ALCOX XPAR:MLINA XPAR:ALGEN XPAR:SIGHT XPAR:AELIS XPAR:ALTAO XPAR:POXEL XPAR:ALNFL VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges ALTHX:France 3VG:Germany

Address 60 avenue Rockefeller, Pepiniere Laennec, Lyon, FRA, 69008

Website https://www.theranexus.com

THX Pharma Formerly Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.

30GF Score

Get the complete analysis for FRA:3VG

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.22

Price

View FRA:3VG Analysis

See Pretax Margin % data for all stocks →